Want to stay updated on the latest mining news?

Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!

Latest News Release

North Peak Announces TSXV Approval of Warrant Expiry Date Extensions

Calgary, Alberta–(Newsfile Corp. – August 24, 2026) – North Peak Resources Ltd. (TSXV: NPR) (OTCQB: NPRLF) (the “Company” or “North Peak“) announces that, further to its news release of July 14, 2026, the TSX Venture Exchange (“TSXV“) has approved the Company’s application to extend by three months the expiry dates of an aggregate of 4,515,831 outstanding common share purchase

Read More »

Maverick Gold and Silver Appoints Michael Leahy to Board of Directors and Grants Stock Options

VANCOUVER, BC, CANADA (August 24, 2026) – Maverick Gold and Silver Corp., (CSE: MAV | FWB: VR61 | OTC: VRCFF) (“Maverick” or the “Company”) is pleased to announce the appointment of Michael Leahy to the Company’s Board of Directors, effective immediately. The Company also announces that Chris Farnworth has resigned as a director of the Company, effective immediately. The Board of

Read More »

Endeavour Silver Says Terronera Blockade Removed, Operations Resume Monday

Endeavour Silver (TSX: EDR) said late Sunday that a blockade that shut down its flagship Terronera mine has been removed, clearing the way for the operation to restart after nearly two weeks offline. The company said the blockade was lifted and that operations would resume on August 24, ending a standoff that began August 12 when members of a neighbouring

Read More »

Agnico Eagle Takes 10% Stake in Radisson Mining in C$57 Million Deal

Agnico Eagle Mines (TSX: AEM) is buying into one of the Abitibi’s more closely watched gold exploration stories, agreeing to take a roughly 10% position in Radisson Mining (TSXV: RDS) through a C$57.2 million strategic investment. The non-brokered private placement has Agnico purchasing 53,420,000 units at C$1.07 apiece. Each unit pairs one common share with half a warrant exercisable at

Read More »

Zacks Small Cap Research – APVO: Focusing on Three Key Areas of Development

By David Bautz, PhD NASDAQ: APVO READ THE FULL APVO RESEARCH REPORT Business Update Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive grant to advance APVO451, and the company’s recently established 50/50 collaboration with Niowave to develop radiopharmaceutical oncology programs. While Aptevo has historically emphasized the breadth of its

Read More »
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -